Managing benzodiazepine withdrawal during pregnancy: case-based guidelines
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Substance use disorders during pregnancy pose serious risks for both the mother and the fetus, demanding careful monitoring by the patient's medical providers. Sedative-hypnotic use, in particular, is common but remains poorly studied. Management of withdrawal from chronic benzodiazepine use during pregnancy presents unique challenges to the treating physician. We present two pregnant patients with dependence on sedative-hypnotic agents, outline principles of benzodiazepine withdrawal, and suggest guidelines for detoxification during pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BZD tapering can be done safely in pregnancy188,189”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [188]
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988 · cited 2×
“Symptom-triggered protocols often rely on scales, such as the WAS or the Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar) (Sullivan et al. 1989).”
MethodEffects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427 · cited 2×
“Benzodiazepine use may be associated with preterm delivery and low birth weight, and specific benzodiazepines, such as lorazepam, may confer a higher risk for anal atresia (Wikner et al. 2007; Bellantuono et al. 2012; Iqbal et al. 2002).”
BackgroundManagement of Alcohol Withdrawal Delirium<subtitle>An Evidence-Based Practice Guideline</subtitle>
Mayo-Smith, M. F. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1405 · Cited by 418 · cited 2×
“Continuous infusion is utilized clinically in patients with high benzodiazepine requirements during the withdrawal period and for those with autonomic instability; however, no studies show a difference in therapeutic efficacy for continuous infusion, and no comparison studies exist to compare this modality to others f…”
BackgroundDolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353 · cited 3×
“Case–control studies have implicated first-trimester benzodiazepine exposure in the development of oral clefts (Dolovich et al. 1998), yet a more recent metaanalysis found the odds ratio of benzodiazepine-associated malformations to be as low as 1.”
BackgroundInfluentialRisk-Benefit Decision Making for Treatment of Depression During Pregnancy
Wisner, K. L., Zarin, D. A., Holmboe, E. S., Appelbaum, P. S., Gelenberg, A. J., Leonard, H. L., & Frank, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1933 · Cited by 265 · cited 2×
“Discussions should be tailored to the patient’s unique clinical factors, including any additional psychiatric history, co-occurring substance use, and the baby’s gestational age (Wisner et al. 2000).”
BackgroundWikner, B. N., Stiller, C., Bergman, U., Asker, C., & Källén, B. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1457 · Cited by 253 · cited 2×
“Benzodiazepine use may be associated with preterm delivery and low birth weight, and specific benzodiazepines, such as lorazepam, may confer a higher risk for anal atresia (Wikner et al. 2007; Bellantuono et al. 2012; Iqbal et al. 2002).”
BackgroundVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195 · cited 2×
“Benzodiazepines are anxiolytic medications that act as agonists at the multi-subunit GABAA receptor via mediation of ligand-gated chloride channels, with inhibitory postsynaptic signaling (Vinkers and Olivier 2012).”
BackgroundFoy, A., March, S., & Drinkwater, V. (1988) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1988.tb00208.x · Cited by 146 · cited 7×
“These are based on a combination of objective measures (e.g., vital signs), observable symptoms (e.g., tremors, flushing), and subjective complaints (e.g., hallucinations, anxiety) for a composite score that determines whether treatment with benzodiazepines is warranted (Foy et al. 1988).”
BackgroundMethodInfluentialMotherisk Rounds: The Fetal Safety of Benzodiazepines: An Updated Meta-analysis
Enato, E. F. O., Moretti, M. E., & Koren, G. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34772-7 · Cited by 123 · cited 1×
“Case–control studies have implicated first-trimester benzodiazepine exposure in the development of oral clefts (Dolovich et al. 1998), yet a more recent metaanalysis found the odds ratio of benzodiazepine-associated malformations to be as low as 1.06 (CI 0.91 to 1.25) (Enato et al. 2001).”
BackgroundInfluentialBenzodiazepine exposure in pregnancy and risk of major malformations: a critical overview
Bellantuono, C., Tofani, S., Di Sciascio, G., & Santone, G. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.09.003 · Cited by 122 · cited 2×
“Benzodiazepine use may be associated with preterm delivery and low birth weight, and specific benzodiazepines, such as lorazepam, may confer a higher risk for anal atresia (Wikner et al. 2007; Bellantuono et al. 2012; Iqbal et al. 2002).”
Background
Research works printed but not linked: 1
- Long LP, Johnson B (2000) Addiction: part I. Benzodiazepines—side effects, abuse risk and alternatives. Am Fam Physician 61(7):2121–2128. http://www.aafp.org/afp/2000/0401/p2121.html
Cited by
Shyken, J. M., Babbar, S., Babbar, S., & Forinash, A. B. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000417 · Cited by 76
Guidelines for the Management of Pregnant Women With Substance Use Disorders
McLafferty, L. P., Becker, M. A., Dresner, N., Meltzer-Brody, S. E., Gopalan, P. R., Glance, J. B., Victor, G. S., Mittal, L. P., Marshalek, P. J., Lander, L. R., et al. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.12.001 · Cited by 75
“Patients with daily misuse should be safely detoxified, preferably in an inpatient setting where a smooth and safe withdrawal period can be carefully balanced with the need for minimizing medication exposures to the fetus.(26)”
BackgroundInfluentialSelf-citationBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“BZD tapering can be done safely in pregnancy 188,189 ; however, ACOG has noted that 186(1278) : [I]t is also critical to consider the risks of a taper for the pregnant individual and the fetus.”
Qato, D. M., & Gandhi, A. B. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03787-5 · Cited by 22
“Such strategies may include addressing benzodiazepine tapering or dose modification during pregnancy [39, 40], improving treatment of comorbid behavioral and mental health issues, and testing the comparative effectiveness of non-pharmacologic interventions.”
BackgroundGopalan, P., Moses-Kolko, E., Valpey, R., Shenai, N., & Smith, E. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.12.005 · Cited by 5
Self-citation
Metadata
- Authors
- Gopalan, P., Glance, J. B., & Azzam, P. N.
- Affiliations
- University of Pittsburgh Medical Center (US)
- VA Boston Healthcare System (US)
- Corresponding author
- Gopalan, Priya
- ORCID
- Gopalan, Priya
- Venue
- Archives of Women's Mental Health
- Published
- 2013-11-24
- Volume
- 17
- Issue
- 2
- Pages
- 167-170
- ISSN
- 1434-1816 (ISSN-L)
- 1435-1102
- OpenAlex
- W1993019523
- Cited by
- 16
- References
- 13
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 7 · 2020: 1 · 2019: 1 · 2018: 2 · 2015: 1 · 2014: 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Women s Mental Health (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- benzodiazepine withdrawal, pregnancy, substance use disorders in pregnancy, benzodiazepine detoxification, withdrawal management, maternal and fetal risk
- MeSH terms
- Adult, Benzodiazepines, Female, Humans, Hypnotics and Sedatives, Pregnancy, Pregnancy Outcome, Substance Withdrawal Syndrome, Treatment Outcome, Practice Guidelines as Topic, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Managing benzodiazepine withdrawal during pregnancy: case-based guidelines. https://app.cochat.ai/papers/10.1007/s00737-013-0388-1
- The paper
- Gopalan, P., Glance, J. B., & Azzam, P. N. (2014). Managing benzodiazepine withdrawal during pregnancy: case-based guidelines. Archives of Women's Mental Health. https://doi.org/10.1007/s00737-013-0388-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.